top of page

SEPTEMBER 17

SEPTEMBER 18

SEPTEMBER 19

A detailed program is provided below. You may also access specific session details by selecting your desired session within the respective hall.

Day 1. September 17th.

SEP17_TATEMODER

Tate Modern

09:00 - 10:30 Session I - Current Concepts and Innovations in Valve Surgery

Chairs: E. Demirsoy; R. Benetis

  • E. Girdauskas  —  Aortic regurgitation

  • G. Dahle  —  Current status of mitral valve interventions

  • T. Folliguet  —  Use of CytoSorb in endocarditis

  • N. Bonaros (virtual)  —  Totally endoscopic aortic valve replacement: why triangulation makes the difference

  • S. E. Shehada  —  Sutureless aortic valve replacement in patients with bicuspid aortic valve: challenging anatomy, promising outcomes

  • N. Dobrilovic (USA)  —  Is it time to switch to a scientific approach for annuloplasty sizing? Current update on the innovation development process for a physiologic mitral annuloplasty ring sizer

  • Th. Tirilomis  —  Aortic valve surgery: specific considerations in the treatment of congenital diseases

  • Dainius Karčiauskas - Samurai Cannulation: Technical Aspects and Institutional Experience at Kaunas Heart Center

  • F.  Casselman – To Be Confirmed

sept17_valve
sept17_global

11:00 - 12:30 Session II - Minimally Invasive Cardiac Surgery: From Innovation to Global Implementation

Chairs: G. Dahle; E. Girdauskas

  • G. Dahle  —  Tendyne in specific situations

  • I. Mavioglu  —  Trans-axillary aortic valve replacement in the endoscopic era

  • S. Marinakis (virtual)  —  Combined AVR and TCRAT from the left

  • E. Demirsoy  —  Bilateral mini-thoracotomy for combined MIDCAB and mitral valve repair

  • M. Kalejs  —  From partial sternotomy to MICLAT-S: our journey in minimally invasive AVR

  • M. Tariq  —  Establishment and outcomes of a MICS programme in a resource-constrained country of low socioeconomic status

  • P. Stradins  —  Innovations and development of contemporary cardiac surgery in Latvia

  • P. Serdari Nia  —  Precision surgery and AI

13:30 - 15:00 Session III - Contemporary Minimally Invasive Coronary Revascularization

sept17_revasculiarization

Chairs: I. Mavioglu; M. Thielmann; K. Ručinskas

  • O. Babliak  —  How to make TCRAT easy for every patient

  • S. Marinakis (virtual)  —  Double thoracoscopic ITA harvesting

  • E. Demirsoy  —  Experience of the minimally invasive approach for multivessel coronary bypass artery surgery in 500 consecutive cases

  • I. Mavioglu  —  Total arterial minimally invasive an-aortic off-pump coronary artery bypass with BITA: how I do it?

  • G. Dahle  —  The integration of ERAS in MICS: a natural symbiosis

  • H. Balkhy (USA, virtual)  —  TECAB

  • M. Thielmann  —  Urgent CABG in acute coronary syndromes: P2Y12 choice and intraoperative haemoadsorption impact on perioperative bleeding – a propensity score-matched analysis of real-world data

  • M. Thielmann  —  DOAC removal during isolated CABG surgery: a report from the ongoing START Registry

15:30 - 17:00 Session IV - Advanced Heart Failure: Contemporary Surgical and Mechanical Circulatory Support

setp17_heartfailure

Chairs: S. E. Shehada; M. Rackauskas

  • M. Rackauskas (USA)  —  Innovations in heart and lung transplantation

  • S. Kucukaksu  —  LVAD therapy: destination therapy vs bridge strategies

  • S. E. Shehada  —  Impella-supported cardiac surgery in patients with severely impaired left ventricular function: optimizing outcomes in high-risk patients

  • S. Kucukaksu  —  Left ventricular assist device therapy for advanced heart failure

  • S. E. Shehada  —  Impella in cardiogenic shock: from rescue therapy to recovery – current evidence and clinical experience

  • J. Kempfert  —  Redo surgery after MitraClip

  • G. Dahle  —  Do we still need surgery for HOCM?

  • P. Terbetas - Trans–atrial implantation of Heart III left ventricular assist device in patients with advanced Heart failure

Sep17_MoMA

Day 1. September 17th.

MoMA

Sep17_dial

09:00 - 10:30 Session I - Haemodialysis: from autologous fistula to bioengineered conduit

Chairs: A. Drobnys; L. Patrone

  • A. Drobnys  —  Basilic vein surgery

  • J. Bernotas  —  Always a radiocephalic approach for AVF formation

  • M. Menegolo  —  Bioresorbable conduit as an AVF graft: insights into a breakthrough technology

  • J. Lindholt  —  Telegraft

  • L. Patrone  —  Endovascular AV fistula

  • S. Norvydas  —  Hybrid haemodialysis access for central venous occlusion

  • J. Bernotas  —  Systemic and vascular changes after AVF formation

  • M. Menegolo  —  Endovascular treatment of innominate and superior cava vein obliteration in haemodialysis patients: the role of balloon-expandable covered stents and intravascular ultrasound (IVUS)

Sep17_PAD1

11:00 - 12:30 Session II - From Iliac to Pedal: Solving the Difficult Lesion

Chairs: H. Zayed; G. Halena

  • R. Morgan  —  Endovascular treatment for common femoral artery PAD - current status

  • B. Migliara  —  New technologies for lesion crossing and treatment in BTK

  • D. Van Heuvel  —  How to select the perfect wire

  • P. Myrcha  —  Mesh vs. fully covered stents for complex iliac lesions: pros, cons, and outcomes

  • G. Halena  —  Common femoral artery into the deep femoral artery stenting: when the ‘no-go zone’ becomes the ‘go-to option’

  • H. Zayed  —  Mid-term Outcomes of Percutaneous Deep Venous Arterialisation

  • P. Ivanova  —  Deep femoral artery – really forgotten?

  • J. Lindholt  —  To be confirmed

Sep17_aorta1

13:30 - 15:00 Session III - Rethinking the Infrarenal Aorta: What Did We Get Right?

Chairs: L. Davidovic; M. Matsagkas

  • F. Thaveau  —  Robotic aortic surgery in 2026: niche technique or missed opportunity?

  • J. Lindholt  —  The changing epidemiology of abdominal aortic aneurysms

  • A. Giannoukas  —  Trends in AAA treatment in Greece

  • F. Moll  —  Thirty years of EVAR: what did we get right and what did we get wrong?

  • E. Huistra  —  Sac regression after FEVAR and BEVAR: what does it tell us about durability?

  • M. Matsagkas  —  Perioperative outcomes using the GORE Excluder Conformable Endograft in patients with extreme proximal aortic neck angulations during EVAR

  • G. Vaitėnas  —  Beyond diameter: AI-based assessment of AAA progression

15:30 - 17:00 Session IV - Complex and Failed Aortic Repair

Chairs: F. Grego; C. Zeebregts

Sep17_aorta2

  • E.-L. Rätsep  —  AAA epidemiology and treatment outcomes in Estonia: a registry-based study from 2010–2025

  • M. Matsagkas   —  Complex endovascular repair following failed EVAR: midterm outcomes

  • C. Csobey-Nowak  —  The planning of physician-modified endografts for juxtarenal aortic disease

  • M. G. Stanisic  —  Recanalization of occluded EVAR limbs: the role of CERAB

  • V. Dabravolskaite  —  Spinal cord ischemia after complex aortic repair: prevention, prediction… or pure luck?

  • C. Zeebregts  —  When anatomy is no longer the limitation: frailty and sarcopenia in complex aortic repair

  • F. Grego  —  Outcomes of branched endovascular aortic repair using an off-the-shelf preloaded inner branch device

sep17_dorsay

Day 1. September 17th.

d'Orsay

09:00 - 10:30 Session I - Beyond the Beaten Track

Chairs: L. Velicka; A. Skrebunas

Free papers

Sep17_miscellan

  • R. Kašėta  —  Endovascular management of hemosuccus pancreaticus secondary to superior mesenteric artery pseudoaneurysm

  • A. Bružas  —  Isolated limb perfusion as a limb-salvage vascular procedure in locally advanced soft tissue sarcoma: case report

  • A. Koureas  —  Endovascular retrieval of a port-a-cath fragment from a pulmonary artery branch

  • P. Čepulis  —  Recurrent celiac trunk pseudoaneurysm with venous fistulization after pancreatectomy

  • G. Stefanidis  —  In vitro proof-of-concept evaluation of a novel balloon-stabilized endovascular catheter for chronic total occlusion crossing

  • G. Stefanidis  —  In vivo feasibility evaluation of a novel balloon-stabilized endovascular catheter for chronic total occlusion crossing in porcine models with implanted occlusions

  • A. Aladaitis  —  Does concomitant valve surgery affect early outcomes after simultaneous carotid endarterectomy and coronary artery bypass grafting? A single-center retrospective study

  • V. Kvedaraitė  —  Associational analysis of gene variants with aortic phenotypic changes and clinical outcomes in thoracic aortic aneurysm and dissection

  • A. Baškytė  —  Vascular surgery in complex oncological treatment: a single-center experience

sept17_carotid

11:00 - 12:30 Session II - The Carotid in Detail

Chairs: R. Bulbulia; K. Paraskevas

Free papers

  • E. Nuellari  —  Carotid endarterectomy: a retrospective comparative study between eversion and patch endarterectomy

  • Y. Shimamura  —  Technical pitfall of retroclavicular carotid–axillary bypass: a case of brachial plexus injury

  • S. Rakhmataliev  —  Comprehensive treatment of patients with nonspecific aortoarteritis of the brachiocephalic arteries

  • J. Myrcha  —  Nickel hypersensitivity as a potential contributor to carotid in-stent restenosis

  • A. Yulbarisov  —  Results of staged revascularization in combined atherosclerotic lesions of the carotid and coronary arteries

  • R. Bukauskienė  —  Impact of baseline cognitive status and cerebral blood flow velocity on postoperative cognitive dysfunction after carotid endarterectomy

sep17_PADshort

13:30 - 15:00 Session III - Saving the Foot

Chairs: R. Gircius; P. Ivanova

Free papers

  • U. Cetingok  —  Difficult lesions in endovascular treatment

  • S. Duesing  —  Improving efficiency of crossing complex, calcified chronic total occlusion (CTO) lesions in chronic limb-threatening ischemia (CLTI)

  • A. Baltrėnas  —  Association between postprocedural pedal arch patency and wound healing / limb salvage after infrainguinal endovascular revascularization in patients with chronic limb-threatening ischemia and tissue loss: a systematic review

  • J. Drilevskis  —  One-year analysis of femoropopliteal revascularisation vs. endovascular intervention in patients with infrainguinal arterial occlusive disease

  • E. M. Liepa  —  Complex surgical management of a spontaneous superficial femoral artery pseudoaneurysm in the setting of Klebsiella pneumoniae sepsis: a case report

  • U. Cetingok  —  Endovascular treatment of heavily calcified femoropopliteal lesions using the UPROOTER™ atherectomy catheter with or without angioplasty: technical description and 12-month results

  • R. Gircius  —  Our approach to complex endovascular BTK cases in Vilnius

  • V. Mosenko  —  Pedal acceleration time and wound healing in patients with chronic limb-threatening ischaemia: a systematic review

sep17_basicstofuture

15:30 - 17:00 Session III - From basics to future solutions

Chairs: G. Lengvenis; A. Kratovska

  • I. Koncar  —  AI in ultrasound examinations: the next frontier in imaging

  • A. Karuzas  —  Cardiac ultrasound AI

  • G. Lengvenis  —  Latest developments in cross-sectional vascular imaging

  • U. Cetingok  —  Difficult lesions in endovascular treatment

  • A. Kratovska  —  Mid-term results of aortoiliac bifurcation kissing stenting with covered stent grafts

  • R. Morgan  —  Role of bioresorbable devices in lower limb PAD- current status

  • G. F. Torsello  —  Intravascular lithotripsy

bottom of page